They have been detected in human body fluids such as cerebrospinal fluid, in the case of GNAI1, EEF1A1, PLP1, NPTN, YWHAH, and ORM2, or urine, in the case of GRIM19, which would facilitate their use as potential biomarkers of interest in PD. This evidence concerns the gene PLP1 and Parkinson disease.